GlassScriptPhysician profile
Umad Ahmad
NPI 1750358834
$3,043.12
in general payments reported to CMS, 2019-2025
14 companies · $667 in 2025
The $667 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $499 · 2020: $60.63 · 2021: $237 · 2022: $327 · 2023: $490 · 2024: $763 · 2025: $667.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,920.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,919.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $1,117.43 | 2022-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Stryker Corporation | $568.55 | 2025 | Flowtriever, Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Janssen Pharmaceuticals, INC | $365.57 | 2019-2022 | |
| Medtronic, INC. | $208.54 | 2022-2024 | Corevalve Evolut R |
| Intuitive Surgical, INC. | $179.34 | 2021-2023 | Da Vinci Surgical System |
| Abiomed | $164.53 | 2019-2024 | Impella |
| Boston Scientific Corporation | $139.69 | 2019 | |
| Philips North America LLC | $132.41 | 2024 | (Cj7) Intact Vascular Undivided |
| Edwards Lifesciences Corporation | $45.21 | 2019 | |
| Amgen INC. | $29.20 | 2019 | |
| Abbott Laboratories | $27.87 | 2019 | |
| Roche Diagnostics Corporation | $27.43 | 2019 | |
| Amarin Pharma, INC. | $20.05 | 2019 | |
| Medtronic Vascular, INC. | $17.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Umad Ahmad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.